Related references
Note: Only part of the references are listed.The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Summary of the Recommendations on Sexual Dysfunctions in Men
Francesco Montorsi et al.
JOURNAL OF SEXUAL MEDICINE (2010)
Incidence rates of erectile dysfunction in the Dutch general population. Effects of definition, clinical relevance and duration of follow-up in the Krimpen Study
BWV Schouten et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2005)
Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: Results of a randomized, double-blind, 26-week placebo-controlled pivotal trial
WJG Hellstrom et al.
UROLOGY (2003)
Incidence of erectile dysfunction in men 40 to 69 years old:: Results from a population-based cohort study in Brazil
ED Moreira et al.
UROLOGY (2003)
Efficacy and safety of tadalafil for the treatment of erectile dysfunction: Results of integrated analyses
GB Brock et al.
JOURNAL OF UROLOGY (2002)
Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'
M Braun et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2000)
Incidence of erectile dysfunction in men 40 to 69 years old: Longitudinal results from the Massachusetts male aging study
CB Johannes et al.
JOURNAL OF UROLOGY (2000)
Share Paper
